Ophthalmology, Retina Specialist · Clearwater, FL
NPI
1588627020
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
505 Druid Rd E
Clearwater, FL, 33756
Phone (727) 447-8008
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
4,477 services
Medicare patients, 2024
447
Average age 78
Drug cost, 2024
$770K
944 prescriptions
Company payments, 2025
$216
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew M Menosky was code 92134 (computerized ophthalmic imaging), 947 times for 408 patients. In total Matthew M Menosky billed 4,477 services in 38 codes, and Medicare paid $324K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 947 | 408 | $29.18 | $28K |
| 92014 Ophthalmological E&M | Office | 570 | 347 | $94.51 | $54K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 522 | 14 | $58.60 | $31K |
| 67028 Intravitreal Injection | Office | 507 | 153 | $82.90 | $42K |
| J7999 Compounded drug, not otherwise classified | Office | 245 | 98 | $67.33 | $16K |
| 99212 Office E&M - Established | Office | 176 | 151 | $27.22 | $4,791 |
| 92012 Ophthalmological E&M | Office | 132 | 97 | $66.76 | $8,812 |
| J3490 Unclassified drugs | Office | 110 | 69 | $62.65 | $6,891 |
| J0178 Injection, aflibercept, 1 mg | Office | 92 | 22 | $645.03 | $59K |
| 99214 Office E&M - Established | Office | 59 | 57 | $104.04 | $6,138 |
| 92250 Angiography | Office | 32 | 32 | $28.54 | $913 |
| 92004 Ophthalmological E&M | Office | 26 | 25 | $97.61 | $2,538 |
By year: 2022 $252K for 4,261 services; 2023 $285K for 4,385 services; 2024 $324K for 4,477 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew M Menosky prescribed most often to Medicare patients was Eylea (Aflibercept), with 213 prescriptions and refills. In total Matthew M Menosky wrote 944 Medicare prescriptions that cost $770K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 213 | 283 | 87 | $478K |
| Prednisolone Acetate Generic | 149 | 198 | 78 | $4,937 |
| Ketorolac Tromethamine Generic | 88 | 99 | 27 | $1,219 |
| Tobramycin Generic | 81 | 83 | 54 | $455 |
| Latanoprost Generic | 67 | 99 | 25 | $326 |
| Timolol Maleate Generic | 66 | 114 | 27 | $349 |
| Atropine Sulfate Generic | 64 | 85 | 45 | $2,191 |
| Vabysmo Faricimab-Svoa | 33 | 44 | 12 | $96K |
| Syfovre Pegcetacoplan/Pf | 29 | 38 | 14 | $83K |
| Brimonidine Tartrate Generic | 23 | 43 | Under 11 | $620 |
| Eylea Hd Aflibercept | 18 | 23 | Under 11 | $47K |
| Loteprednol Etabonate Generic | 17 | 21 | Under 11 | $1,864 |
| Ozurdex Dexamethasone | 16 | 38 | 13 | $30K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 13 | 26 | Under 11 | $269 |
Brand drugs: 529 claims; generic drugs: 415 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew M Menosky $216 ($216 in general payments such as food, travel and fees) from 6 companies. The largest payer was Dompe US, Inc. with $58.33.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.